Eosinophilia in the cerebrospinal fluid of children with shunts implanted for the treatment of internal hydrocephalus.
Cerebrospinal fluid (CSF) eosinophilia was observed in 26 of 404 children after the implantation of shunts for the treatment of internal hydrocephalus. High levels of 65% and 78% were recorded in two cases, which are reported in detail. In the remaining 24 cases, CSF eosinophilia ranging between 1% and 3% was found. None of the cases with CSF eosinophilia had blood eosinophilia. The cases indicate that a reaction to the material used for the shunt should be considered along with possible parasitic infestations in patients with such findings.
Tzvetanova
E M
EM
Tzekov
C T
CT
D002557:Cerebrospinal Fluid Shunts; D002675:Child, Preschool; D003616:Dandy-Walker Syndrome / Q000134:cerebrospinal fluid / Q000628:therapy; D004802:Eosinophilia / Q000134:cerebrospinal fluid*; D004804:Eosinophils / Q000166:cytology; D005260:Female; D006801:Humans; D006849:Hydrocephalus / Q000134:cerebrospinal fluid* / Q000628:therapy; D007223:Infant; D007231:Infant, Newborn; D008591:Meningomyelocele / Q000134:cerebrospinal fluid / Q000628:therapy; D006475:Vitamin K Deficiency Bleeding / Q000134:cerebrospinal fluid / Q000628:therapy